| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |